Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Sanofi's Xenpozyme Is First Drug Approved For Rare Genetic Disease ASMD
Aug 31 2022
•
By
Jessica Merrill
FDA approved the first drug for ASMD, a rare genetic disease. • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from New Products
More from Scrip